2-Arachidonoylglycerol in Cardiovascular Disease: Angel or Demon?

Cardiovasc Drugs Ther. 2023 Aug;37(4):617. doi: 10.1007/s10557-022-07393-1. Epub 2022 Oct 24.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Arachidonic Acids
  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / epidemiology
  • Endocannabinoids
  • Glycerides
  • Humans

Substances

  • glyceryl 2-arachidonate
  • Arachidonic Acids
  • Endocannabinoids
  • Glycerides